KELSEY STEPHEN MICHAEL (See Remarks) sold 24.1% of their position (92.53K shares) of REVOLUTION MEDICINES, INC. on the open market
Open‑market sale worth $18.72M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+52.50K
Price / share
$42.45
Trade value
$2.23M
% of position
Common Stock
Shares
+40.03K
Price / share
$40.74
Trade value
$1.63M
% of position
Common Stock
Shares
−800.00
Price / share
$198.55
Trade value
$158.84K
% of position
Common Stock
Shares
−11.83K
Price / share
$200.11
Trade value
$2.37M
% of position
Common Stock
Shares
−13.37K
Price / share
$200.78
Trade value
$2.68M
% of position
Common Stock
Shares
−21.45K
Price / share
$201.75
Trade value
$4.33M
% of position
Common Stock
Shares
−18.87K
Price / share
$203.06
Trade value
$3.83M
% of position
Common Stock
Shares
−17.95K
Price / share
$203.87
Trade value
$3.66M
% of position
Common Stock
Shares
−5K
Price / share
$204.84
Trade value
$1.02M
% of position
Common Stock
Shares
−3.27K
Price / share
$205.81
Trade value
$672.99K
% of position
Net shares
+0.00
Net value
-$14.87M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/11/2026 | M · Option Exercise | +52.50K | $42.45 | $2.23M | 18.0% | 291.88K | 344.38K |
| Common Stock Direct | 9/11/2026 | M · Option Exercise | +40.03K | $40.74 | $1.63M | 11.6% | 344.38K | 384.41K |
| Common Stock Direct | 9/11/2026 | S · Sale | −800.00 | $198.55 | $158.84K | 0.2% | 384.41K | 383.61K |
| Common Stock Direct | 9/11/2026 | S · Sale | −11.83K | $200.11 | $2.37M | 3.1% | 383.61K | 371.77K |
| Common Stock Direct | 9/11/2026 | S · Sale | −13.37K | $200.78 | $2.68M | 3.6% | 371.77K | 358.41K |
| Common Stock Direct | 9/11/2026 | S · Sale | −21.45K | $201.75 | $4.33M | 6.0% | 358.41K | 336.96K |
| Common Stock Direct | 9/11/2026 | S · Sale | −18.87K | $203.06 | $3.83M | 5.6% | 336.96K | 318.09K |
| Common Stock Direct | 9/11/2026 | S · Sale | −17.95K | $203.87 | $3.66M | 5.6% | 318.09K | 300.14K |
| Common Stock Direct | 9/11/2026 | S · Sale | −5K | $204.84 | $1.02M | 1.7% | 300.14K | 295.15K |
| Common Stock Direct | 9/11/2026 | S · Sale | −3.27K | $205.81 | $672.99K | 1.1% | 295.15K | 291.88K |
| Total | +0.00 | -$14.87M | ||||||
Stock Option (Right to Buy)
Common Stock
52.50K shares
Shares
−52.50K
Strike price
42.45
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
128.10K shares
Shares
−40.03K
Strike price
40.74
Held after
88.07K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock52.50K shares | 9/11/2026 | M · Option Exercise | −52.50K | 42.45 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock128.10K shares | 9/11/2026 | M · Option Exercise | −40.03K | 40.74 | — | 88.07K |